Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors [Phase 1]

View source ↗

Summary

This is an ongoing Phase 1 clinical trial evaluating safety, tolerability, and pharmacokinetics of DCR-PDL1 in adults with solid tumors. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• DCR-PDL1

Snippet

Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | Conditions: Solid Tumors, Adult | Phase 1 | Status: RECRUITING